共查询到20条相似文献,搜索用时 31 毫秒
1.
Expression of two functionally different androgen receptors in a patient with androgen insensitivity
P. M. Holterhus G. H. G. Sinnecker H. A. Wollmann D. Struve N. Homburg K. Kruse O. Hiort 《European journal of pediatrics》1999,158(9):702-706
Recently, we demonstrated a previously unknown high rate of de novo mutations of the androgen receptor (AR) gene in androgen
insensitivity syndrome (AIS) with some resulting in somatic mosaicism of mutant and wild type AR alleles. However, data on
the genotype-phenotype relationship in the latter patients are sparse. We present here a 46,XY newborn with ambiguous genitalia
carrying a mosaic of an 866 GTG (Val) → ATG (Met) mutation with the wild type AR gene. This mutation has usually been associated
with complete AIS. Accordingly, we found markedly impaired transactivation due to the mutant Met866 AR. Essential information arose from Scatchard analysis of methyltrienolone binding on cultured genital skin fibroblasts.
We demonstrated for the first time the expression of two functionally different ARs (Kd1: 5.58 nM = mutant, Kd2: 0.06 nM = wild type) in one AIS individual. This finding not only represents an important confirmation for the presence
of the somatic mosaicism in the patient, it also indicates the most likely molecular mechanism responsible for the unexpectedly
strong virilization of the patient: Androgen action through the wild type AR expressed by part of the somatic cells.
Conclusions The present case clearly demonstrates the molecular mechanism by which somatic mosaicism of the androgen receptor gene can
modulate in vivo androgen action. It underlines the importance of particular notice on somatic mosaicism in all androgen insensitivity
syndrome patients carrying de novo mutations of the androgen receptor gene.
Received: 24 August 1998 / Accepted in revised form: 5 January 1999 相似文献
2.
Skordis N Patsalis PC Bacopoulou I Sismani C Sultan C Lumbroso S 《Journal of pediatric endocrinology & metabolism : JPEM》2005,18(3):241-246
INTRODUCTION: 5alpha-Steroid reductase deficiency (5alphaSRD) is an autosomal recessive enzymatic deficiency. Mutations in the 5alpha-steroid reductase type 2 gene (SRD5A2) result in male pseudohermaphroditism caused by decreased dihydrotestosterone (DHT) synthesis--a key hormone of virilization of male external genitalia. AIM: To study for the first time patients from the Greek Cypriot population, describe their clinical characteristics, and identify the genetic mutations of the SRD5A2 gene. PATIENTS AND METHODS: Three unrelated patients with 46,XY karyotype born with ambiguous genitalia were examined. Patient 1 was raised as a girl and was diagnosed with partial androgen insensitivity syndrome, based on the clinical picture and incomplete laboratory investigation at the age of 4 years, and underwent gonadectomy. For this patient sequencing analysis of all five exons of the SRD5A2 gene and exons 2 to 8 of the androgen receptor (AR) gene was performed. Patients 2 and 3 were also born with ambiguous genitalia. The hCG test for these two patients was informative of 5alphaSRD, as it showed elevated T/DHT ratio after stimulation. Despite genetic counseling, both families decided to raise their infants as females because of severe under-virilization. Sequencing of the SRD5A2 gene was also completed for both patients. RESULTS: No mutations were found in the AR sequence for patient 1. Patients 1 and 3 were found homozygous for the mutation A/G at splice junction intron 1/exon 2 and patient 2 was found heterozygous for the same A/G substitution and also heterozygous for an additional mutation, Pro181Leu, in exon 3. CONCLUSIONS: The same mutation in the SRD5A2 gene was identified in three unrelated patients, in both homozygous and heterozygous form. This splice mutation was previously reported in Turkish patients. This underlying genetic abnormality may be characteristic for the Eastern Mediterranean region and is likely due to an ancestor effect. 相似文献
3.
Denys-Drash syndrome is a rare genetic disorder featuring the triad of congenital nephropathy, Wilms tumor, and intersex disorders (XY under-virilization or XY female). Denys-Drash syndrome is associated with constitutional mutations in the Wilms tumor suppressor gene WT1. Unlike WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome, with its complete deletion of one copy of WT1, Denys-Drash syndrome is generally caused by a dominant-negative mutation. We present a new case of Denys-Drash syndrome in a patient initially diagnosed with XY ambiguous genitalia/partial androgen insensitivity syndrome, who was found to have a novel nonsense mutation in exon 6 leading to a stop codon and hence a truncated protein. Based on lessons learned from this patient, the diagnosis of Denys-Drash syndrome should be considered in the presence of ambiguous genitalia and partial androgen insensitivity. 相似文献
4.
M G Forest P Mollard M David Y Morel J Bertrand 《Archives fran?aises de pédiatrie》1990,47(2):107-113
A familial form of incomplete androgen insensitivity syndrome (AIS) is reported. The index case was first seen at 9 months of age for ambiguous genitalia. Diagnosis of AIS, suspected but first discarded on the basis of an androgen sensitivity test, was finally made at puberty on the discordance between poor virilization and elevated levels of both testosterone and LH, a florid gynecomastia, and the exclusion of any enzymatic defect in testosterone biosynthesis of 5 alpha-reductase deficiency. Androgen receptors in public skin were within the limits of normal for total number, with normal affinity. Familial occurrence included 2 first cousins born 7 and 10 years later, a maternal grand-uncle with similar ambiguous genitalia, and a maternal uncle with the gynecomastia-preserved fertility syndrome. This case report illustrates the heterogeneity of AIS in a given family and the difficulty of and early positive diagnosis in a newborn presenting with sexual ambiguity. 相似文献
5.
Jeske YW McGown IN Cowley DM Oley C Thomsett MJ Choong CS Cotterill AM 《Journal of pediatric endocrinology & metabolism : JPEM》2007,20(8):893-908
We genotyped the androgen receptor (AR) gene in 31 Australasian patients with androgen insensitivity syndrome (AIS). The entire coding region of AR was examined including analysis of polymorphic CAG and GGN repeats in all patients. AR defects were found in 66.7% (6/9) of patients with complete AIS (CAIS) and 13.6% (3/22) of patients with partial AIS (PAIS). A novel deletion (N858delG) leading to a premature stop codon was found in CAIS patient P1. CAIS patient P2 has a novel deletion (N2676delGAGT) resulting in a stop at codon 787. These mutations would result in inactivation of AR protein. A novel insertion of a cysteine residue in the first zinc finger of the AR DNA-binding domain (N2045_2047dupCTG) was found in CAIS patient P3. PAIS patient P4 has a novel amino acid substitution (Arg760Ser) in the AR ligand binding domain, which may impair ligand binding. Five patients were found to have previously reported AR mutations and no mutations were identified in the remaining patients. 相似文献
6.
Complete androgen insensitivity syndrome (CAIS) is a relatively rare X-linked disorder caused by androgen receptor gene (AR) mutations that result in complete impairment of genital virilisation. In these individuals, no müllerian derivatives are usually found; however, several sporadic cases of CAIS with müllerian remnants have been reported. In this paper, we report two novel point mutations of the AR gene resulting in two cases of CAIS with incomplete müllerian regression. Molecular studies of cases 1 and 2 showed novel missense mutations of the AR gene, with a methionine to threonine substitution at codon 749 (base 2608 TC) in exon 5 and a methionine to lysine substitution at codon 787 (base 2722 TA) in exon 6. Both patients received bilateral gonadectomy and inguinal hernia repair. The excised gonads proved to be testes with incomplete regression of the müllerian structures. Conclusion:müllerian structures can be present in androgen insensitivity syndrome and the presence of a uterus therefore does not exclude this disorder. Further study of these patients may promote a better understanding of the pathogenesis.Abbreviations AIS androgen insensitivity syndrome - AR androgen receptor - CAIS complete androgen insensitivity syndrome - hAR human androgen receptor - MIS müllerian inhibiting substance - PAIS partial androgen insensitivity syndrome 相似文献
7.
Damiani D Mascolli MA Almeida MJ Jaubert F Fellous M Dichtchekenian V Tobo PR Moreira-Filho CA Setian N 《Journal of pediatric endocrinology & metabolism : JPEM》2002,15(9):1553-1556
One of the unusual findings in androgen insensitivity syndrome (AIS) is the persistence of Mullerian derivatives. Several hypotheses have been advanced to explain such persistence: the coincidental occurrence of mutations affecting the androgen receptor (AR) and the synthesis and/or action of anti-Müllerian hormone (AMH); the loss of AMH paracrine action due to early testicular descent; the exposure to drugs such as diethylstilbestrol. We describe a patient with complete AIS for whom surgical and laboratory findings rule out all these hypotheses. She has a missense mutation on the AR gene but no mutations were detected on the genes coding for AMH and AMH receptor. The gonads were found very close to the Mullerian structures (enough to exert a paracrine action), gonadal tissue stained positively for AMH, and yet Mullerian derivatives were present and well developed. These findings indicate the possibility of interactions between the androgen receptor and AMH action. 相似文献
8.
G. H. G. Sinnecker O. Hiort E. M. Nitsche P.-M. Holterhus K. Kruse 《European journal of pediatrics》1997,156(1):7-14
In the genetic male, mutations of the androgen receptor (AR) gene cause phenotypes ranging from female to subfertile male. Binding assays on genital skin fibroblasts and DNA analysis alone provide incomplete information about receptor function. We used the sex hormone-binding globulin (SHBG) response to stanozolol as a measure of AR function and correlated the results with phenotypes which were classified according to the degree of defective masculinization. Of the 34 patients investigated, 9 had complete, and 14 had partial androgen insensitivity syndrome (AIS) with predominantly female, ambiguous, or predominantly male phenotype. Eleven subjects served as controls. Mutations were characterized using polymerase chain reaction-single strand conformation polymorphism analysis and direct DNA sequencing. DNA analysis revealed two major deletions, two minor defects leading to premature stop codons in exon 1, and 19 point mutations in the DNA- and hormone-binding domains of the AR gene. After stanozolol, SHBG remained unchanged in patients with complete AIS (102.0 ± 3.8 [SE]%; range 92.4%–129% of the initial value). The SHBG decrease was diminished in partial AIS with predominantly female (83.8% ± 1.7%; range 81.3%–87.0%), ambiguous (80.4% ± 4.4%, range 68.4%–89.1%), and predominantly male (mean 65.9% ± 4.9%, range 48.6%– 80.8%) phenotypes, and normal in controls (51.4% ± 2.1%, range 35.6%–62.1%). Differences between controls and each AIS group were statistically significant (P< < 0.05 – < 0.0001). A close correlation was found between the degree of undermasculinization (AIS phenotype) and the SHBG response. Conclusions The SHBG test provides functional information about the severity of the receptor defect in vivo and hence adds to the structural information provided by DNA analysis. It detects receptor defects due to mutations within the entire gene, including the DNA-binding domain, and is a rapid, simple, and cost effective procedure. It may provide useful information for the diagnosis and management of affected children. 相似文献
9.
We report a female newborn with characteristic signs of Antley-Bixler syndrome (ABS) such as midface hypoplasia, radiohumeral
synostosis and multiple joint contractures. The newborn also presented ambiguous genitalia, stage Prader V, and congenital
adrenal hyperplasia. The mother experienced midterm virilization due to a pregnancy luteoma. Her elevated androgen levels
and virilization symptoms normalized post partum without treatment. The newborn had elevated serum testosterone and 17-OH-progesterone
levels which remained elevated because of a 21-hydroxylase deficiency. The child's treatment in order of priority was: hydrocortisone
substitution, craniofacial/skeletal anomaly management and surgical correction of the external genitalia. Mutations in the
genes for fibroblast growth factor (FGF) 8 and receptors FGFR1, FGFR2, and FGFR3 were not detected.
Conclusion A newborn girl with manifestations of the Antley-Bixler syndrome showed severe virilization probably caused by the association
of a mild 21-hydroxylase deficiency and maternal hyperandrogenism due to a pregnancy luteoma. Abnormalities of androgen metabolism
may be responsible for virilization reported in other cases of the Antley-Bixler syndrome.
Received: 14 May 1999 / Accepted: 3 August 1999 相似文献
10.
G. H. G. Sinnecker O. Hiort E. M. Nitsche P.-M. Holterhus K. Kruse German Collaborative Intersex Study Group 《European journal of pediatrics》1996,156(1):7-14
In the genetic male, mutations of the androgen receptor (AR) gene cause phenotypes ranging from female to subfertile male.
Binding assays on genital skin fibroblasts and DNA analysis alone provide incomplete information about receptor function.
We used the sex hormone-binding globulin (SHBG) response to stanozolol as a measure of AR function and correlated the results
with phenotypes which were classified according to the degree of defective masculinization. Of the 34 patients investigated,
9 had complete, and 14 had partial androgen insensitivity syndrome (AIS) with predominantly female, ambiguous, or predominantly
male phenotype. Eleven subjects served as controls. Mutations were characterized using polymerase chain reaction-single strand
conformation polymorphism analysis and direct DNA sequencing. DNA analysis revealed two major deletions, two minor defects
leading to premature stop codons in exon 1, and 19 point mutations in the DNA- and hormone-binding domains of the AR gene.
After stanozolol, SHBG remained unchanged in patients with complete AIS (102.0 ± 3.8 [SE]%; range 92.4%–129% of the initial
value). The SHBG decrease was diminished in partial AIS with predominantly female (83.8% ± 1.7%; range 81.3%–87.0%), ambiguous
(80.4% ± 4.4%, range 68.4%–89.1%), and predominantly male (mean 65.9% ± 4.9%, range 48.6%– 80.8%) phenotypes, and normal in
controls (51.4% ± 2.1%, range 35.6%–62.1%). Differences between controls and each AIS group were statistically significant
(P< < 0.05 – < 0.0001). A close correlation was found between the degree of undermasculinization (AIS phenotype) and the SHBG
response.
Conclusions The SHBG test provides functional information about the severity of the receptor defect in vivo and hence adds to the structural
information provided by DNA analysis. It detects receptor defects due to mutations within the entire gene, including the DNA-binding
domain, and is a rapid, simple, and cost effective procedure. It may provide useful information for the diagnosis and management
of affected children.
Received: 13 February 1996 / Accepted: 4 June 1996 相似文献
11.
Galli-Tsinopoulou A Hiort O Schuster T Messer G Kuhnle U 《Journal of pediatric endocrinology & metabolism : JPEM》2003,16(2):149-154
Mutations in the coding sequence of the androgen receptor (AR) gene result in a wide range of androgen insensitivity syndromes (AIS). We report an extended family in which at least five male individuals in different generations suffer from partial AIS. The index patient presented at birth with ambiguous genitalia; the karyotype was 46,XY and subsequent sex assignment male. Elevated stimulated testosterone (T) and normal baseline gonadotropins were found. Family history revealed four additional adult males affected with various abnormalities of their external genitalia. Molecular analysis of the coding sequence of the AR gene revealed in all a novel point mutation in exon 6, changing threonine to isoleucine at codon position 800 in the hormone-binding domain. We conclude that phenotypic variations in mild AR defects are striking and can remain undetected even until late in life. 相似文献
12.
Keisuke Nagasaki Reiko Horikawa Kazuo Fujisawa Ikue Hata Yosuke Shigematsu Toshiaki Tanaka 《Clinical Pediatric Endocrinology》2004,13(1):59-64
Female pseudohermaphroditism is caused by several etiologies. Here we report a
case of aromatase deficiency who showed ambiguous genitalia and maternal virilization
during pregnancy. The mother had noticed her own virilization from 16 wk of gestation
without androgen exposure and had low urinary estriol levels (5~10 μg/ml
at 35 wk of gestation). At birth, the patient presented severe virilization (Prader V),
and was assigned as a male with a micropenis and unpalpable testes but the patient had a
normal female karyotype and a uterus and cystic ovaries found by magnetic resonance
imaging. The patient had a increase in serum 17α-hydroxy progesterone levels (basal 4.9 →
37 ng/ml after a single 0.25 mg/m2 infusion of ACTH), but the increase in
adrenal androgen was not sufficient to virilize the external genitalia.
Dehydroepiandrosterone, 17α-hydroxy pregnenolone and deoxycorticosterone were within the
normal ranges. These findings suggested a diagnosis of nonadrenal female
pseudohermaphroditism. From the clinical features and biochemical data, we
endocrinologically diagnosed her as having an aromatase deficiency. The aromatase gene is
now under investigation for definite diagnosis. We finally agreed that aromatase
deficiency should be suspected when both the mother and the newborn have been
virilized. 相似文献
13.
BA Evans IA Hughes CL Bevan MN Patterson JW Gregory 《Archives of disease in childhood》1997,76(6):529-531
The androgen insensitivity syndrome is a heterogeneous disorder with a wide spectrum of phenotypic abnormalities, ranging from complete female to ambiguous forms that more closely resemble males. The primary abnormality is a defective androgen receptor protein due to a mutation of the androgen receptor gene. This prevents normal androgen action and thus leads to impaired virilisation. A point mutation of the androgen receptor gene affecting two siblings with partial androgen insensitivity syndrome is described. One had cliteromegaly and labial fusion and was raised as a girl, whereas the other sibling had micropenis and penoscrotal hypospadias and was raised as a boy. Both were shown to have the arginine 840 to cysteine mutation. The phenotypic variation in this family is thus dependent on factors other than abnormalities of the androgen receptor gene alone. 相似文献
14.
Chong Kun Cheon 《European journal of pediatrics》2011,170(1):1-8
The aim of this article is to review the literature on steroid 5alpha-reductase type 2 deficiency (5α-RD2) to provide clinicians
with information to guide their management of patients with this disorder. The 5alpha-reductase type 2 is encoded by the 5alpha-reductase
type 2 gene (SRD5A2) on chromosome 2 and is predominantly expressed in external genital tissues and the prostate. Mutations of the SRD5A2 gene leads to an uncommon autosomal recessive disorder affecting sexual differentiation in individuals with 46,XY karyotype;
their phenotype can range from almost normal female structures to a distinct male phenotype with ambiguous genitalia at birth.
These phenotypes result from impaired conversion of testosterone to dihydrotestosterone due to mutations in the SRD5A2 gene. Patients exhibit virilization at puberty without breast development, which is often accompanied by gender identity
change from female to male. More than 40 mutations have been reported in all five exons of the SRD5A2 gene. Phenotype–genotype correlations for 5α-RD2 have not been well established. The newborn phenotypes of male pseudohermaphrodites
with 5α-RD2, partial androgen insensitivity syndrome (PAIS), or 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) enzyme
deficiency may be indistinguishable. We conclude that steroid 5α-RD2 should be included in the differential diagnosis of newborns
with 46,XY DSD. It is important that the diagnosis be made in infancy by biochemical and molecular studies before gender assignment
or any surgical intervention because these patients should be considered males at birth. 相似文献
15.
Accepted 5 March 1997
The androgen insensitivity syndrome is a heterogeneous disorder with a wide spectrum of phenotypic abnormalities, ranging from complete female to ambiguous forms that more closely resemble males. The primary abnormality is a defective androgen receptor protein due to a mutation of the androgen receptor gene. This prevents normal androgen action and thus leads to impaired virilisation. A point mutation of the androgen receptor gene affecting two siblings with partial androgen insensitivity syndrome is described. One had cliteromegaly and labial fusion and was raised as a girl, whereas the other sibling had micropenis and penoscrotal hypospadias and was raised as a boy. Both were shown to have the arginine 840 to cysteine mutation. The phenotypic variation in this family is thus dependent on factors other than abnormalities of the androgen receptor gene alone.
相似文献
The androgen insensitivity syndrome is a heterogeneous disorder with a wide spectrum of phenotypic abnormalities, ranging from complete female to ambiguous forms that more closely resemble males. The primary abnormality is a defective androgen receptor protein due to a mutation of the androgen receptor gene. This prevents normal androgen action and thus leads to impaired virilisation. A point mutation of the androgen receptor gene affecting two siblings with partial androgen insensitivity syndrome is described. One had cliteromegaly and labial fusion and was raised as a girl, whereas the other sibling had micropenis and penoscrotal hypospadias and was raised as a boy. Both were shown to have the arginine 840 to cysteine mutation. The phenotypic variation in this family is thus dependent on factors other than abnormalities of the androgen receptor gene alone.
相似文献
16.
M Maes P A Lee R D Jeffs C Sultan C J Migeon 《American journal of diseases of children (1960)》1980,134(5):470-473
A family with partial androgen insensitivity syndrome exhibited considerable variation in phenotypic expression of their androgen resistance. One subject died at 2 1/2 years of age of a Wilms' tumor. In the two living members, one had a micropenis with otherwise normal genitalia, while the other had a small phallus, perineoscrotal hypospadias, bifid scrotum, and persistence of a vaginoutricular pouch. At puberty, plasma androgens and serum gonadotropins increased to normal or elevated values. However, despite adequate endogenous plasma testosterone levels and testosterone therapy, these patients showed poor virilization and were sterile. Studies of cultured sexual skin fibroblasts showed adequate 5 alpha-reductase activity and normal receptor affinity and capacity for dihydrotestosterone. An X-linked mode of inheritance is postulated, although autosomal dominance cannot be ruled out. 相似文献
17.
Olaf Hiort George Klauber Mare Cendron Gernot H. G. Sinnecker Lutz Keim Eberhard Schwinger Hubert J. Wolfe David W. Yandell 《European journal of pediatrics》1994,153(5):317-321
Development of male external genitalia is dependent on androgens, and karyotypic males lacking appropriate levels of androgens or functionally normal receptors may show abnormal virilization. Mutations in the androgen receptor gene cause abnormal receptor function and diverser mutations may be associated with heterogenous clinical signs of androgen insensitivity. In this study, we have searched for the existence of androgen receptor gene mutations carried by some patients with hypospadias. Genomic DNA samples from peripheral blood leucocytes from 21 patients with different degrees of hypospadias were studied. Analysis of the androgen receptor gene was performed by exon-specific amplification using polymerase chain reaction, single strand conformation polymorphism analysis, and direct genomic sequencing. Although a silent polymorphism was identified in exon 1 of the androgen receptor gene, the majority of patients studied (20/21) did not carry androgen receptor gene mutations. One patient with severe hypospadias and bilateral cryptorchidism was found to carry a point mutation in exon 8. We conclude that mutations in the androgen receptor gene may be carried by subset of patients with genital ambiguity presenting primarily with hypospadias, but this is not the underlying cause in the majority of cases. Characterization of this genetic defect may be important for classification and subsequent conservative therapeutic approaches for these patients. 相似文献
18.
Phenotypic variation and detection of carrier status in the partial androgen insensitivity syndrome.
J A Batch H R Davies B A Evans I A Hughes M N Patterson 《Archives of disease in childhood》1993,68(4):453-457
The partial androgen insensitivity syndrome occurs in 46,XY subjects with phenotypes ranging from perineoscrotal hypospadias with cryptorchidism and micropenis (mild undervirilisation) to clitoromegaly and partial labial fusion (marked undervirilisation). Within an affected family, wide variation in the degree of genital ambiguity between individuals can be seen. Two cousins of a previously reported subject who had severe genital ambiguity and partial androgen insensitivity were investigated. Neither of the cousins had genital abnormalities as marked as the index case, who also had qualitatively abnormal androgen binding and two mutations of the androgen receptor gene. Despite marked phenotypic differences between the index case and his cousins, similar androgen binding and the same androgen receptor mutations were shown in the cousins. Furthermore, one of the androgen receptor gene mutations has been shown in the mother and sister of one of the boys indicating that they are carriers. Thus phenotypic variation in families affected by partial androgen insensitivity is dependent on factors other than abnormalities of the androgen receptor gene alone. Although carrier status in partial androgen insensitivity can be determined, the severity of genital abnormalities in an affected offspring cannot be reliably predicted. 相似文献
19.
JA Batch HR Davies BA Evans IA Hughes MN Patterson 《Archives of disease in childhood》1993,68(4):453-457
The partial androgen insensitivity syndrome occurs in 46,XY subjects with phenotypes ranging from perineoscrotal hypospadias with cryptorchidism and micropenis (mild undervirilisation) to clitoromegaly and partial labial fusion (marked undervirilisation). Within an affected family, wide variation in the degree of genital ambiguity between individuals can be seen. Two cousins of a previously reported subject who had severe genital ambiguity and partial androgen insensitivity were investigated. Neither of the cousins had genital abnormalities as marked as the index case, who also had qualitatively abnormal androgen binding and two mutations of the androgen receptor gene. Despite marked phenotypic differences between the index case and his cousins, similar androgen binding and the same androgen receptor mutations were shown in the cousins. Furthermore, one of the androgen receptor gene mutations has been shown in the mother and sister of one of the boys indicating that they are carriers. Thus phenotypic variation in families affected by partial androgen insensitivity is dependent on factors other than abnormalities of the androgen receptor gene alone. Although carrier status in partial androgen insensitivity can be determined, the severity of genital abnormalities in an affected offspring cannot be reliably predicted. 相似文献
20.
Choi JH Kim GH Seo EJ Kim KS Kim SH Yoo HW 《Journal of pediatric endocrinology & metabolism : JPEM》2008,21(6):545-553
The aim of this study was to assess the clinical and endocrinological features, and to analyze AR and SRD5A2 genes in patients with 46,XY disorders of sex development (DSD). This study included 20 patients from 19 families showing clinical features of 46,XY DSD. Molecular analysis was performed of the AR and SRD5A2 genes, as well as endocrinological evaluations, such as 17a-hydroxyprogesterone, plasma renin activity, aldosterone, adrenocorticotropic hormone and hCG stimulation test. Out of 20 patients with 46,XY DSD, only one (5%) displayed androgen insensitivity syndrome (AIS), and four (20%) were 5alpha-reductase deficient by mutation analysis. The patient with AIS revealed significant elevation of serum testosterone following hCG stimulation. The patient with 5alpha-reductase deficiency with a homozygous p.R246Q mutation had a low basal dihydrotestosterone level. The patient with p.Q6X/p.R246Q mutations showed a moderately elevated testosterone/dihydrotestosterone ratio following hCG stimulation. Endocrinological tests are not reliable for the etiological diagnosis of AIS and 5alpha-reductase deficiency due to variable reference ranges of hormonal profiles according to the age and the severity of the enzyme defect. DNA analysis may be employed as a tool for the early and precise diagnosis of patients with 46,XY DSD, and genetic counseling can be used for families at risk. 相似文献